Cultural diversity in Alzheimer disease: The interface between biology, belief, and behavior

Alzheimer Disease and Associated Disorders

Volumn 19, Issue 4, 2005, Pages 250-255

  Chui, Helena C ^a,b   Gatz, Margaret ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4; CITALOPRAM; CLOZAPINE; DESIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALLELE; ALZHEIMER DISEASE; BIOLOGY; CLINICAL FEATURE; CONFERENCE PAPER; CULTURAL ANTHROPOLOGY; DEPRESSION; DOSE RESPONSE; DRUG METABOLISM; ETHNOLOGY; GENE IDENTIFICATION; HEALTH BEHAVIOR; HUMAN; INCIDENCE; INTERVENTION STUDY; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MULTIFACTORIAL INHERITANCE; MULTIINFARCT DEMENTIA; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; UNITED STATES; ATTITUDE TO HEALTH; CULTURAL FACTOR; MINORITY GROUP; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS;

ALZHEIMER DISEASE; CROSS-CULTURAL COMPARISON; CULTURAL DIVERSITY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MINORITY GROUPS; RISK FACTORS; UNITED STATES;

EID: 33644977988     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000190802.03717.20     Document Type: Conference Paper

References (61)

1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-1342.
2. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.
3. Tang MX, Cross P, Andrew H, et al. Incidence of Alzheimer disease in African Americans, Carribean Hispanics, and Caucasians in Northern Manhattan. Neurology. 2001;56:49-56.
4. Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739-747.
5. Demirovic J, Prineas R, Lowenstein D, et al. Prevalence of dementia in three ethnic groups: The South Florida Program on Aging and Health. Ann Epidemiol. 2003;13:472-478.
6. Clark CM, Clark CM, DeCarli C, et al. The symptoms of AD appear to begin at a younger age in Latinos than Anglos. Arch Neuro. 2005;62:774-778.
7. Green RC, Cupples LA, Rodney G, et al. Risk of dementia among White and African American relatives of patients with Alzheimer disease. JAMA. 2002;287:329-336.
8. White L, Petrovitch H, Ross W, et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA. 1996;276:955-960.
9. Graves AB, Larson EB, Edland SD, et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state: The Kame Project. J Epidemiol. 1996;144:760-771.
10. Mayeux R. Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol. 2003;60:161-163.
11. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278:1349-1356.
12. Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E e4 and Alzheimer's disease in elderly Nigerians. Ann Neurol. 1995;38:463-465.
13. Sahota A, Yang M, Gao S, et al. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Ann Neurol. 1997;42:659-661.
14. Tang MX, Maestre G, Tsai WY, et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African-Americans, Caucasians and Hispanics in New York City. Am J Hum Genet. 1996;58:574-584.
15. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a bi-racial urban community: relation to apoliprotein E allele status. Arch Neurol. 2003;60:185-189.
16. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997;277:813-817.
17. Schneider JA, Wilson RS, Bienias JL, et al. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62:1148-1155.
18. Breteler MMB. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci. 2000;903:457-465.
19. Roher AE, Rahman A, Kokjohn TA, et al. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke. 2004;35:2623-2627.
20. Blain JF, Poirier J. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease. Expert Rev Neurother. 2004;4:823.
21. Zekraoui L, Lagarde JP, Raisonnier A, et al. High frequency of the apoliprotein E4 allele in African Pygmies and most of the African populations in sub-Sahara Africa. Hum Biol. 1997;69:575-581.
22. Maestre G, Ottman R, Stern Y, et al. Apoliprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.
23. Desai PP, Hendrie HC, Evans RM, et al. I. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genetics Part B. 2003;116B:98-101.
24. Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol. 1997;54:1399-1405.
25. Mortimer JA, Snowdon DA, Markesbery WR. Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol. 2003;25:671-679.
26. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751-755.
27. Larrieu S, Letenneur L, Helmer C, et al. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Aging Nutr Health. 2004;8:150-154.
28. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280:5892-5901.
29. Graves AB, Rajaram L, Bowen JD, et al. Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County, WA: the Kame Project. J Gerontol B Psychol Sci Soc Sci. 1999;54:S154-S161.
30. Ross GW, Petrovitch H, White LR, et al. Characterization of risk factors for vascular dementia. The Honolulu Asia Aging Study. Neurology. 1999;53:337-343.
31. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
32. Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Dectection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
33. Deleted in press.
34. Lindeman RD, Romero LJ, Hundley R, et al. Prevalence of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. Diabetes Care. 1998;21:959-966.
35. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
36. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among whites, blacks, and Hispanics from the same community of Northern Manhattan. Am J Epidemiol. 1998;3:264.
37. Sacco RL, Boden-Albabla B, Abel G, et al. Race-ethnic disparities in the impact of stroke risk factors. The Northern Manhattan Stroke Study. Stroke. 2001;32:1725-1731.
38. Rocca WA, Kokmen E. Frequency and distribution of vascular dementia. Alzheimer Dis Assoc Disord. 1999;13:S9-S14.
39. Chui H, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia: a multi-center study of reliability and validity. Arch Neurol. 2000;57:191-199.
40. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. American Geriatrics Society. 2004;52:195-204.
41. Chambless LE, Heiss G, Shahar E, et al. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2004;160:259-269.
42. Bravata DM, Wells CK, Gulanski B, et al. Racial disparities in stroke risk factors: the impact of socioeconomic status. Stroke. 2005;36:1507-1511.
43. Sudano JJ, Baker DW. Antihypertensive medication use in Hispanic adults: a comparison with black adults and white adults. Med Care. 2001;39:575-587.
44. Satish S, Stroup-Benham CA, Espino DV, et al. Undertreatment of hypertension in older Mexican Americans. J Am Ger Society. 1998;46:405-410.
45. Humma LM, Terra SG. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management. Am J Health Syst Pharm. 2002;59:1241-1252.
46. Parra EJ, Hoggart CJ, Bonilla C, et al. Relation of type 2 diabetes to individual admixture and candidate gene polymorphisms in the Hispanic American population of San Luis Valley, Colorado. J Med Genet. 2004;41:116.
47. Cox NJ, Frigge M, Nicolae DL, et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet. 1999;21:213-215.
48. Vozarova B, Fernandez-Real JM, Knowler WC, et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet. 2003;112:409-413.
49. Hicks LS, Fairchild DG, Horng MS, et al. Determinants of JNC VI guidelines adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429-434.
50. Lewis LB, Sloane DC, Nascimento LM, et al. REACH Coalition of the African Americans Building a Legacy of Health Project. African Americans' access to healthy food options in South Los Angeles restaurants. Am J Public Health. 2005;95:668-673.
51. Fitzgibbon ML, Blackman LR. Reduction of health risk in minority populations. In: Camic PM, SJ Knight SJ (eds). Clinical Handbook of Health Psychology: A Practical Guide to Effective Interventions. Seattle: Hogrefe & Huber; 1998: 559-581.
52. Sue D. Health risk factors in diverse cultural groups. In: Eisler RM, Hersen M (eds). Handbook of Gender, Culture, and Health. Mahwah NJ: Lawrence Erlbaum; 2000:85-104.
53. Kelty MF, Hoffman RR III, Ory MG, et al. Behavioral and sociocultural aspects of aging, ethnicity, and health. In: Eisler RM, Hersen M (eds). Handbook of Gender, Culture, and Health. Mahwah, NJ: Lawrence Erlbaum; 2000:139-158.
54. Cushman WC, Reda DJ, Perry HM, et al. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Arch Intern Med. 2000;160:825-831.
55. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Nature Reviews. 2003;4:937-947.
56. Xie HG, Kim RB, Wood AJ, et al. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol. 2001;41:815-850.
57. Masimirembwa, Hasler. Genetic polymorphism of drug metabolizing enzymes in African populations: implications for the use of neuroleptics and antidepressants. Br Res Bul. 1997;44:567-571.
58. Jones RS. Chow TW, Gatz M. Asian Americans and Alzheimer's disease: assimilation, culture, and beliefs. J Aging Stud. in press.
59. Ferguson A, Barg F, Augsburger D, et al. Genes or stress? Ethnic perceptions about the causes of Alzheimer's disease. Alzheimer's Association International Conference on Prevention of Dementia. Washington, DC: 2003.
60. Roberts S, Akinleye D, Hipps YG, et al. Beliefs about prevention and treatment of Alzheimer's disease among African Americans. Alzheimer's Association International Conference on Prevention of Dementia. Washington, DC: 2005.
61. Ayalon L, Areán PA. Knowledge of Alzheimer's disease in four ethnic groups of older adults. Int J Geriatr Psychiatry. 2004;19:51-57.